Long-term outcome with interstitial brachytherapy in the management of patients with early-stage breast cancer treated with breast-conserving therapy

International Journal of Radiation Oncology Biology Physics

Volumn 37, Issue 4, 1997, Pages 845-852

  Vicini, Frank A ^a,b   Horwitz, Eric M ^a   Lacerna, Mario D ^a   Dmuchowski, Carl F ^b   Brown, Douglas M ^a   White, Julia ^c   Chen, Peter Y ^a   Edmundson, Gregory K ^a   Gustafson, Gary S ^a   Clarke, Daniel H ^d   Gustafson, Gregory S ^a   Matter, Richard C ^a   Martinez, Alvaro A ^a  

^a Departments of Radiationn Oncology   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d Northern Virginia Cancer Center   (United States)

Author keywords

Brachytherapy; Breast conserving therapy; Low dose rate; Radiation therapy

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; BREAST BIOPSY; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; ESTHETICS; FEMALE; HUMAN; IRRADIATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; BIOPSY; BRACHYTHERAPY; BREAST; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; IRIDIUM RADIOISOTOPES; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 0030940676     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00606-2     Document Type: Article

References (43)

1. American Joint Committee on Cancer. Breast. In: Bearhrs, O. H.; Henson, D. R.; Hutter, R. V. P.; Kennedy, B. J., eds. Manual for staging of cancer, 4th ed. Philadelphia: J. B. Lippincott; 1992:149-154.
2. Bedwinek, J. M.; Perez, C. A.; Kramer, S.; Brady, L.; Goodman, R.; Grundy, G. Irradiation as the primary management of Stage I and II adenocarcinoma of the breast. Analysis of the RTOG breast registry. Cancer Clin. Trials 3:11-18; 1980.
3. Clarke, D. H.; Edmundson, G. K.; Martinez, A. A.; Matter, R. C.; Warmelink, C. The utilization of 1-125 seeds as a substitute for Ir-192 seeds in temporary interstitial implants: An overview and description of the William Beaumont Hospital technique. Int. J. Radiat. Oncol. Biol. Phys. 15:1027-1033; 1988.
4. Clarke, D. H.; Le, M. G.; Sarrazin, D.; Lacombe, M.; Fontaine, F.; Travagli, J. P.; May-Levin, F.; Contesso. G.; Arriagada, R. Analysis of local-regional relapses in patients with early stage breast cancers treated with excision and radiotherapy: Experience of the Institut Gustave-Roussy. Int. J. Radiat. Oncol. Biol. Phys. 11:137-145: 1985.
5. Clarke, D. H.; Martinez, A. Identification of patients who are at high risk for locoregional breast cancer recurrence after conservative surgery and radiotherapy: A review article for surgeons, pathologists, and radiation and medical oncologists. J. Clin. Oncol. 10:474-483; 1992.
6. Clarke, D. H.; Martinez, A.; Cox, R. S. Analysis of cosmetic results and complications in patients with stage I and II breast cancer treated by biopsy and irradiation. Int. J. Radiat. Oncol. Biol. Phys. 9:1807-1813; 1983.
7. Clarke, D. H.; Vicini, F. A.; Jacobs, H.; Rowland, C.; Kuske, R. High dose rate brachytherapy for breast cancer. In: Nag, S., ed. High dose rate brachytherapy: A textbook. Arnonk, Ni: Futura Publishing Co.; 1994:321-329.
8. Cox, D. R. Regression models and life tables. J. R. Stat. Soc. 34:187-220; 1972.
9. de la Rochefordiere, A.; Abner, A. L.; Silver, B.; Vicini, F. A.; Recht, A.; Harris, J. R. Are cosmetic results following conservative surgery and radiation therapy for early stage breast cancer dependent upon technique? Int. J. Radiat. Oncol. Biol. Phys. 23:925-931; 1992.
10. Deore, S. M; Sarin, R.; Dinshaw, K. A.; Shrivastava, S. K. Influence of dose-rate and dose per fraction on clinical outcome of breast cancer treated by external beam irradiation plus iridium-192 implants: Analysis of 289 cases. Int. J. Radiat. Oncol. Biol. Phys. 26:601-606; 1993.
11. Fisher, B.; Andersen, S. Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP Trials. World J. Surg. 18:63-69; 1994.
12. Fourquet, A.; Campana, F.; Mosseri, V.; Centigoz, R.; Luciani, S.; Labib, A.; Asselain, B.; Vilcoq, J. R. Iridium-192 vs. cobalt 60 boost in 3-7 cm breast cancer treated by irradiation alone: Final results of a randomized trial. Radiother. Oncol. 34:119-120; 1995.
13. Glicksman, A. S.; Leith, J.T. Radiobiological considerations of brachytherapy. Oncology 2:25; 1988.
14. Hall, E. J.; Lam, Y. M. The renaissance in low dose rate interstitial implants: Radiobiological consideration. In: Vaeth, J., ed. Frontiers of radiation therapy and oncology. Basel, Switzerland: Karger; 1978:21-34.
15. Hammer, J.; Track, C.; Pakisch, B. The impact of boost type (E-, Ir-192 HDR) on the cosmetic result in conservative breast cancer treatment. Radiother. Oncol. 31:7; 1994.
16. Hartsell, W.; Galinsky, D.; Griem, K.; Recine, D. C.; Murthy, K. Lumpectomy with negative margins: Is a boost dose to the tumor bed necessary? Int. J. Radiat. Oncol. Biol. Phys. 30:246; 1994.
17. Holland, R.; Connolly, J.; Gelman, R.; Mravunac, J.; Hendricks, J.; Schnitt, S.; Harris, J. R. Nature and extent of residual cancer in the breast related to the intraductal component in the primary tumor. Int. J. Radiat. Oncol. Biol. Phys. Suppl. 15:182-183; 1988.
18. Jacobson, J. A.; Danforth, D. N.; Cowan, K.; D'Angelo, T.; Steinberg, S.; Pierce, L.; Lippman, M. E.; Lichter, A.; Glatstein, E.; Okunieff, P. Ten-year results of a comparison of conservation with mastectomy in the treatment of Stage I and II breast cancer. N. Engl. J. Med. 332:907-911; 1995.
19. Kaplan, E. L.; Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:457-481; 1958.
20. Krishnan, L.; Jewell, W. R.; Krishnan, E. C.; Cherian, R.; Lin, F. Breast cancer with an extensive intraductal component: Treatment with immediate interstitial breast irradiation. Radiology 183:273-276; 1992.
21. Krishnan, L.; Jewell, W.; Mansfield, C. M.; Reddy, E. K.; Thomas, J. H.; Krishnan, M. S. Early stage breast cancer: Local control after conservative surgery and radiation therapy with immediate interstitial boost. Radiology 187:95-98; 1993.
22. Leung, S.; Otmezquine, Y.; Calitchi, E.; Mazeron, J. J.; LeBourgeois, J. P.; Pierquin, B. Locoregional recurrences following radical external beam irradiation and interstitial implantation for operable breast cancer - A 23 year experience. Radiother. Oncol. 5:1-10; 1986.
23. Mansfield, C. M. Intraoperative Ir-192 implantation for early breast cancer - Techniques and results. Cancer 66:1-5; 1990.
24. Mansfield, C. M.; Komarnicky, L. T.; Schwartz, G. F.; Rosenberg, A. L.; Krishnan, L.; Jewell, W. R.; Rosato, F. E.; Moses, M. L.; Barbot, D.; Cohn, H. E.; Gillum, D. R.; Taylor, J.; Benammar, A.; Swenssen, L. Perioperative implantation of Ir-192 as the boost technique for Stage I and II breast cancer: 10 year results in 655 patients. Radiology 192:33-36; 1994.
25. Mantel, N.; Haenszel, W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 22:719-748; 1959.
26. McCormick, B.; Wesson, M. F.; Cox, L.; Osborne, M. P.; Petrek, J.; Kinne, D. W. Iridium-192 implants for primary breast cancer: Experience with placement at the time of wide local excision. Int. J. Radiat. Oncol. Biol. Phys. 15:745-748; 1988.
27. National Institutes for Health Consensus Conference: Treatment of early stage breast cancer. JAMA 265:391-395; 1991.
28. Pezner, R. D.; Lipsett, J. A.; Desai, K.; Vora, N.; Terz, J.; Hill, R.; Luk, K. H. To boost or not to boost: Decreasing radiation therapy in conservative breast cancer treatment when "inked" tumor resection margins are pathologically free of cancer. Int. J. Radiat. Oncol. Biol. Phys. 14:873-877; 1988.
29. Pierquin, B.; Owen, R.; Maylin, C.; Otmezguine, Y.; Raynal, M.; Mueller, W.; Hannoun, S. Radical radiation therapy of breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 6:17-24; 1980.
30. Pierquin, B.; Huart, J.; Raynal, M.; Otmezguine, Y.; Calitchi, E.; Mazeron, J.; Ganem, G.; LeBourgeois, J.; Marinello, G.; Julien, M.; Brun, B.; Fevilhade, F. Conservative treatment for breast cancer: long-term techniques and results (15 year). Radiother. Oncol. 20:16-23; 1991.
31. Ray, G. R.; Fish, V. J.; Marzoni, F. A.; Trollope, M. L.; Hews, M.; Gribble, M. Biopsy and definitive radiation therapy in Stage I and II adenocarcinoma of the female breast: Analysis of cosmesis and the role of electron breast supplementation. Int. J. Radiat. Oncol. Biol. Phys. 9:23-28; 1983.
32. Recht, A.; Silver, B.; Schnitt, S.; Connolly, J.; Hellman, S.; Harris, J. R. Breast relapse following primary radiation therapy for early breast cancer. I. Classification, frequency, and salvage. Int. J. Radiat. Oncol. Biol. Phys. 11:1271-1276; 1985.
33. Rose, M. A.; Olivetto, J.; Cady, B.; Kaufman, C; Osteen, R.; Silver, B.; Recht, A.; Harris, J. R. Conservative surgery and radiation therapy for early stage breast cancer. Long-term cosmetic results. Arch. Surg. 124:153-157; 1989.
34. Sarin, R.; Dinshaw, K. A.; Shrivastava, S. K.; Sharma, V.; Deore, S. M. Therapeutic factors influencing the cosmetic outcome and late complications in the conservative management of early stage breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 27:285-292; 1993.
35. Stefanik, D.; Brereton, H. D.; Lee, T. C. Fat necrosis following breast irradiation for carcinoma: Clinical presentation and diagnosis. Breast 8:4-6; 1982.
36. Syed, A. M. N.; Puthawala, A.; Fleming, P.; Neblett, D.; Gowdy, R. A.; Sheikh, K.; George, F. W.; Eads, D.; McNamara, C. Combination of external and interstitial irradiation in the primary management of breast carcinoma. Cancer 46:1360-1365; 1980.
37. Touboul, E.; Beklacemi, Y.; Ozsahin, M.; Lefranc, J. P.; Uzan, S.; Bellaiche, A.; Kerbas, D.; Balosso, J.; Schwartz, L. H.; Isikli, L.; Pene, F.; Blondon, J. Conservative surgery and radiation therapy in the treatment of stage I and II breast cancer: Influence of type of boost (electrons vs. iridium-192 implant) on local control. Int. J. Radiat. Oncol. Biol. Phys. Suppl. 30:245-246; 1994.
38. Van Zyl, J. A.; Muller, A. G. S. Breast conserving treatment for stage I and II cancer. S. Afr. Med. J. 75:519-523; 1989.
39. Veronesi, U.; Banfi, A.; Salvadori, B.; Luini, A.; Saccozzi, R.; Zucali, R.; Marubini, E.; Del Vecchio, M.; Boracchi, P.; Marchini, S.; Merson, M.; Sacchini, V.; Riboldi, G.; Santoro, G. Breast conservation is the treatment of choice in small breast cancer: Long-term results of a randomized trial. Eur. J. Cancer 26:668-670; 1990.
40. Vicini, F. A.; Eberlein, T. J.; Connolly, J. L.; Recht, A.; Abner, A.; Schnitt, S. J.; Silen, W.; Harris, J. R. The optimal extent of resection for patients with early stage breast cancers treated with conservative surgery and radiotherapy. Ann. Surg. 214:200-208; 1991.
41. Vicini, F.; Recht, A.; Abner, A.; Boyages, J.; Cady, B.; Connolly, J.L.; Gelman, R.; Osteen, R. T.; Schnitt, S. J.; Silen, W.; Harris, J. R. Recurrence in the breast following treatment of patients with early stage breast cancer with conservative surgery and radiation therapy. J. Natl. Cancer Inst. Monogr. 11:33-39; 1992.
42. Vicini, F. A.; White, J.; Gustafson, G.; Matter, R.; Clarke, D. H.; Edmundson, G.; Martinez, A. The use of iodine-125 seeds as a substitute for iridium-192 seeds in temporary interstitial breast implants. Int. J. Radiat. Oncol. Biol. Phys. 27:561-566; 1993.
43. Wazer, D. E.; DiPetrillo, T.; Schmidt-Ulrich, R.; Weld, L.; Smith, T. J.; Marchant, D. J.; Robert, N. Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early stage breast carcinoma. J. Clin. Oncol. 10:356-363; 1992.